A Phase 2, Randomized Prospective, Double-Masked, Vehicle-Controlled Study to assess the Efficacy andSafety of Nexagon (NEXAGON) Applied Topically in Subjects with Corneal Persistent Epithelial Defects(PED) Resulting from Severe Ocular Chemical and/or

Project: Research project

Project Details

Description

A Phase 2, Randomized Prospective, Double-Masked, Vehicle-Controlled Study to assess the Efficacy and Safety of Nexagon (NEXAGON) Applied Topically in Subjects with Corneal Persistent Epithelial Defects (PED) Resulting from Severe Ocular Chemical and/or
StatusActive
Effective start/end date7/15/197/31/24

Funding

  • OCUNEXUS THERAPEUTICS, INC

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.